.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Argus Health
Colorcon
Cipla
Chubb
Moodys
Fish and Richardson
Express Scripts
US Department of Justice
AstraZeneca

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040058

« Back to Dashboard
NDA 040058 describes PROCHLORPERAZINE, which is a drug marketed by Able, Alpharma Us Pharms, G And W Labs, Baxter Hlthcare, Watson Labs, Hospira, West-ward Pharms Int, Teva Parenteral, Athenex Inc, Emcure Pharms Ltd, Wyeth Ayerst, Smith And Nephew, Marsam Pharms Llc, Morton Grove, Sandoz, Duramed Pharms Barr, Teva Pharms, Ivax Sub Teva Pharms, and Mylan, and is included in thirty NDAs. It is available from three suppliers. Additional details are available on the PROCHLORPERAZINE profile page.

The generic ingredient in PROCHLORPERAZINE is prochlorperazine maleate. There are nineteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.

Summary for NDA: 040058

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details

Pharmacology for NDA: 040058

Ingredient-typePhenothiazines

Suppliers and Packaging for NDA: 040058

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROCHLORPERAZINE
prochlorperazine
SUPPOSITORY;RECTAL 040058 ANDA G&W Laboratories, Inc. 0713-0135 0713-0135-10 1000 BLISTER PACK in 1 CARTON (0713-0135-10) > 1 SUPPOSITORY in 1 BLISTER PACK
PROCHLORPERAZINE
prochlorperazine
SUPPOSITORY;RECTAL 040058 ANDA G&W Laboratories, Inc. 0713-0135 0713-0135-12 12 BLISTER PACK in 1 CARTON (0713-0135-12) > 1 SUPPOSITORY in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUPPOSITORY;RECTALStrength25MG
Approval Date:Nov 24, 1993TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Dow
Accenture
Boehringer Ingelheim
Daiichi Sankyo
Julphar
Colorcon
US Army
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot